Cargando…
The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is through Blocking the Interaction between S100A1 and RAGE V Domain
The S100A1 protein in humans is a calcium-binding protein. Upon Ca(2+) binding to S100A1 EF-hand motifs, the conformation of S100A1 changes and promotes interactions with target proteins. RAGE consists of three domains: the cytoplasmic, transmembrane, and extracellular domains. The extracellular dom...
Autores principales: | Parveen, Nuzhat, Chiu, Wei-Jung, Shen, Li-Ching, Chou, Ruey-Hwang, Sun, Chung-Ming, Yu, Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856166/ https://www.ncbi.nlm.nih.gov/pubmed/36671465 http://dx.doi.org/10.3390/biom13010081 |
Ejemplares similares
-
Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain
por: Khan, Md. Imran, et al.
Publicado: (2019) -
S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
por: Khan, Md. Imran, et al.
Publicado: (2018) -
S100P Interacts with p53 while Pentamidine Inhibits This Interaction
por: Katte, Revansiddha H., et al.
Publicado: (2021) -
Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast
por: Chiou, Jian Wei, et al.
Publicado: (2016) -
S100B as an Antagonist To Interfere with the Interface
Area Flanked by S100A11 and RAGE V Domain
por: Dowarha, Deepu, et al.
Publicado: (2018)